Cilian AG is a biotechnology company developing and marketing a novel protein expression system based on ciliates.
Cilian is an emerging biotechnology company developing and marketing a novel expression system. The Company uses a species of Ciliates, a eukaryotic single-cell organism, for the production of enzymes and therapeutic proteins. While Ciliates secrete a number of therapeutically relevant enzymes with high expression rates by nature, recombinant proteins are produced by Ciliates using genetically modified cells.Leveraging the unique capabilities of the Ciliates, the Company aims to produce proteins at an unmatched quality and price, thereby fulfillingits mission to improve human health by facilitating access to biopharmaceuticals.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Apr 2, 2004 | Series B | €5M | 1 | Limburg Ventures | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Limburg Ventures | Yes | Series B |